Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records
Abstract Background Cardiovascular diseases are a common cause of death among patients with type 2 diabetes (T2DM). Major adverse cardiovascular event (MACE) risks can be significantly reduced under adequate glycemic control (GC). This study aims to identify factors that influence MACE risk among pa...
Saved in:
| Main Authors: | Haowen Hsu, Paul Thomas Kocis, Ariana Pichardo‐Lowden, Wenke Hwang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Journal of Diabetes |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1753-0407.13604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucose-lowering medication selection in patients with diabetes and acute cerebrovascular accident
by: O. V. Zanozina, et al.
Published: (2020-03-01) -
Triglyceride-glucose index: a novel predictor of major adverse cardiovascular events and cerebrovascular events in patients with acute ST-segment elevation myocardial infarction
by: Ruibin Wei, et al.
Published: (2025-05-01) -
Meal Glycemic Load, Meal Frequency, and Alertness: Mediation Effect of Glucose Concentration
by: Perdana S. T. Suyoto, et al.
Published: (2024-03-01) -
Assessment of agreement between estimated average glucose and single-point fasting plasma glucose with varying glycemic control
by: Ijeoma A. Meka, et al.
Published: (2025-07-01) -
Predictive value of serum myeloperoxidase (MPO) concentration combined with triglyceride-glucose index (TyG) for major adverse cardiaovascular events (MACE) in patients with coronary heart disease
by: Adila Wulamu, et al.
Published: (2025-12-01)